Radiation Therapy for Soft Tissue Sarcoma: Indications and Controversies for Neoadjuvant Therapy, Adjuvant Therapy, Intraoperative Radiation Therapy, and Brachytherapy

Surg Oncol Clin N Am. 2016 Oct;25(4):841-60. doi: 10.1016/j.soc.2016.05.012. Epub 2016 Aug 6.

Abstract

Soft tissue sarcomas are rare mesenchymal cancers that pose a treatment challenge. Although small superficial soft tissue sarcomas can be managed by surgery alone, adjuvant radiotherapy in addition to limb-sparing surgery substantially increases local control of extremity sarcomas. Compared with postoperative radiotherapy, preoperative radiotherapy doubles the risk of a wound complication, but decreases the risk for late effects, which are generally irreversible. For retroperitoneal sarcomas, intraoperative radiotherapy can be used to safely escalate the radiation dose to the tumor bed. Patients with newly diagnosed sarcoma should be evaluated before surgery by a multidisciplinary team that includes a radiation oncologist.

Keywords: Brachytherapy; Intraoperative radiation therapy; Radiation therapy; Sarcoma.

Publication types

  • Review

MeSH terms

  • Antibiotics, Antineoplastic / therapeutic use
  • Brachytherapy / adverse effects
  • Brachytherapy / methods*
  • Combined Modality Therapy
  • Humans
  • Neoadjuvant Therapy
  • Radiotherapy Dosage
  • Radiotherapy, Adjuvant
  • Sarcoma / drug therapy
  • Sarcoma / radiotherapy*
  • Sarcoma / surgery
  • Soft Tissue Neoplasms / drug therapy
  • Soft Tissue Neoplasms / radiotherapy*
  • Soft Tissue Neoplasms / surgery
  • Treatment Outcome

Substances

  • Antibiotics, Antineoplastic